Brief: Xeris Biopharma Announces CEO Succession Plan

Xeris Biopharma Holdings

08/07/2024 13:04

July 8 (Reuters) - Xeris Biopharma Holdings Inc
 XERS.O :
    * XERIS BIOPHARMA ANNOUNCES CEO SUCCESSION PLAN
    * JOHN SHANNON TO SUCCEED PAUL EDICK AS CEO AND BOARD
DIRECTOR
    * XERIS BIOPHARMA - MARLA S. PERSKY TO BE CHAIRPERSON OF THE
BOARD
    * ANTICIPATES Q2 '24 REVENUE TO EXCEED $47 MILLION
    * XERIS BIOPHARMA - REAFFIRMS YEAR-END 2024 CASH GUIDANCE OF
$55
MILLION TO $75 MILLION
    * Q2 REVENUE VIEW $44.9 MILLION -- LSEG IBES DATA

Source text for Eikon:  ID:nBw8Dw45ma 
Further company coverage:  XERS.O 

 ((Reuters.Briefs@thomsonreuters.com;))